Target intelligence / Profile preview

Codanin-1 (CDAN1)

Target
CDAN1
Molecular classification
Other (scaffold/chromatin assembly-associated protein)
01

Overview

**Codanin-1 (CDAN1)** is an essential and ubiquitously expressed protein involved in the maintenance of nuclear structure, chromatin assembly, and the cell cycle[3][4]. It interacts with histone chaperones ASF1A and ASF1B and is implicated in chromatin condensation by sequestering histone chaperones, thereby impacting nucleosome formation and downstream gene expression[1][2]. Mutations in CDAN1 cause congenital dyserythropoietic anemia type I, leading to defective red blood cell production[3]. While it has a central role in basic cell biology and erythropoiesis, it is not an established therapeutic target, and no drug interactions or established biomarker roles have been reported[1][3][4].

Other names
Codanin-1CDAN1UNQ664/PRO1295CDA-ICDAICDA1CDAN1ADLTPRO1295congenital dyserythropoietic anemia type I proteindiscs lost homolog
02

Biological functions

Chromatin assembly/nucleosome assemblyRegulation of nuclear structureCell cycle regulation (notably S phase)Erythropoiesis (red blood cell development)
03

Disease associations

Other (congenital dyserythropoietic anemia type I, a rare inherited blood disorder)
04

Safety considerations

Mutations cause congenital dyserythropoietic anemia type I, which includes macrocytic anemia, ineffective erythropoiesis, and risk of secondary hemochromatosis[3][4].CDAN1 is essential for normal development; knockout is embryonically lethal in mice[1].

Beyond the preview

Go deeper on Codanin-1 (CDAN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codanin-1 (CDAN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call